SG11201404168SA - FERRIC CITRATE CONTAINING SUBSTANTIALLY NO β-OXIDIZED IRON HYDROXIDE - Google Patents
FERRIC CITRATE CONTAINING SUBSTANTIALLY NO β-OXIDIZED IRON HYDROXIDEInfo
- Publication number
- SG11201404168SA SG11201404168SA SG11201404168SA SG11201404168SA SG11201404168SA SG 11201404168S A SG11201404168S A SG 11201404168SA SG 11201404168S A SG11201404168S A SG 11201404168SA SG 11201404168S A SG11201404168S A SG 11201404168SA SG 11201404168S A SG11201404168S A SG 11201404168SA
- Authority
- SG
- Singapore
- Prior art keywords
- iron hydroxide
- ferric citrate
- containing substantially
- oxidized iron
- citrate containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/41—Preparation of salts of carboxylic acids
- C07C51/412—Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/265—Citric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
- C07F15/02—Iron compounds
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P10/00—Technologies related to metal processing
- Y02P10/20—Recycling
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011007887 | 2011-01-18 | ||
| US201161438303P | 2011-02-01 | 2011-02-01 | |
| PCT/JP2012/050885 WO2012099139A1 (en) | 2011-01-18 | 2012-01-18 | FERRIC CITRATE CONTAINING SUBSTANTIALLY NO β-OXIDIZED IRON HYDROXIDE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201404168SA true SG11201404168SA (en) | 2014-10-30 |
Family
ID=46515762
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201404168SA SG11201404168SA (en) | 2011-01-18 | 2012-01-18 | FERRIC CITRATE CONTAINING SUBSTANTIALLY NO β-OXIDIZED IRON HYDROXIDE |
| SG10201506517XA SG10201506517XA (en) | 2011-01-18 | 2012-01-18 | Ferric Citrate Containing Substantially No ß-Oxidized Iron Hydroxide |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201506517XA SG10201506517XA (en) | 2011-01-18 | 2012-01-18 | Ferric Citrate Containing Substantially No ß-Oxidized Iron Hydroxide |
Country Status (8)
| Country | Link |
|---|---|
| US (4) | US20120238622A1 (en) |
| EP (2) | EP2666764A4 (en) |
| JP (8) | JP2012162522A (en) |
| AU (1) | AU2012207967B2 (en) |
| CA (1) | CA2824646C (en) |
| MY (1) | MY171864A (en) |
| SG (2) | SG11201404168SA (en) |
| WO (1) | WO2012099139A1 (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2563819C2 (en) | 2009-07-21 | 2015-09-20 | Керикс Байофармасьютикалз, Инк. | Drug forms of iron (iii) citrate |
| MY171864A (en) * | 2011-01-18 | 2019-11-05 | Japan Tobacco Inc | Iron(iii) citrate, substantially free of beta-iron hydroxide oxide |
| WO2015198304A1 (en) | 2014-06-22 | 2015-12-30 | Dexcel Pharma Technologies Ltd. | Pharmaceutical compositions comprising ferric citrate and methods for the production thereof |
| EP3331521A1 (en) * | 2015-08-05 | 2018-06-13 | Lupin Limited | Process for the preparation of pharmaceutical grade ferric citrate |
| WO2019093491A1 (en) * | 2017-11-10 | 2019-05-16 | 株式会社トクヤマ | Method for producing ferric citrate hydrate |
| WO2019142941A1 (en) * | 2018-01-22 | 2019-07-25 | 株式会社トクヤマ | Method of producing ferric citrate |
| JP2019167305A (en) * | 2018-03-23 | 2019-10-03 | 株式会社トクヤマ | Method for producing ferric citrate |
| JP7335268B2 (en) | 2018-11-14 | 2023-08-29 | 株式会社トクヤマ | Method for producing ferric citrate hydrate |
| JP7335269B2 (en) | 2018-11-14 | 2023-08-29 | 株式会社トクヤマ | Method for producing ferric citrate hydrate |
| JP7175235B2 (en) * | 2019-04-19 | 2022-11-18 | 株式会社トクヤマ | Method for producing ferric citrate hydrate |
| CN110105194A (en) * | 2019-05-10 | 2019-08-09 | 上海万巷制药有限公司 | A kind of preparation method of pharmaceutical grade ironic citrate |
| WO2020243674A1 (en) | 2019-05-30 | 2020-12-03 | Compass Minerals Usa Inc. | Micronutrient foliar solutions |
| CA3157327A1 (en) | 2019-11-08 | 2021-05-14 | Giuseppe Barreca | Process for the preparation of ferric organic compounds |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT279048B (en) | 1967-07-04 | 1970-02-25 | Pharmazeutische Fabrik Montavit Gmbh | Process for the preparation of new, soluble and stable organic iron (III) complex compounds and injection solutions thereof |
| IT1222654B (en) | 1987-09-14 | 1990-09-12 | Schering Ag | IRON-CITRATE MICELLAR COMPLEX |
| US5753706A (en) | 1996-12-16 | 1998-05-19 | Hsu; Chen Hsing | Methods for treating renal failure |
| CN1315174A (en) | 2000-03-31 | 2001-10-03 | 苏荣仁 | Composite medicine for treating renale failure |
| JP4617449B2 (en) | 2002-07-11 | 2011-01-26 | ヴィキュロン ファーマシューティカルズ インコーポレイテッド | N-hydroxyamide derivative having antibacterial activity |
| CN1202067C (en) | 2002-09-09 | 2005-05-18 | 苏荣仁 | Medicinal grade ferrum citricum iron-59 citrate and its preparation method |
| US8093423B2 (en) * | 2003-02-19 | 2012-01-10 | Globoasia, Llc | Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same |
| TWI335218B (en) * | 2003-02-19 | 2011-01-01 | Panion & Bf Biotech Inc | Ferric organic compounds, uses thereof and methods of making same |
| US6903235B2 (en) * | 2003-10-08 | 2005-06-07 | Panion & Bf Biotech Inc. | Pharmaceutical-grade ferric citrate |
| US8273553B2 (en) * | 2004-11-02 | 2012-09-25 | Ares Trading S.A. | Production of growth hormone in serum-free cell culture medium for mammalian cells |
| CA3050453C (en) | 2005-08-18 | 2021-07-27 | Panion & Bf Biotech Inc. | Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same |
| CN100591654C (en) * | 2005-11-30 | 2010-02-24 | 苏荣仁 | Refining method capable of increasing citric-acid solubility |
| ES2580127T3 (en) * | 2006-01-30 | 2016-08-19 | Panion & Bf Biotech Inc. | Chronic Nephropathy Treatment Procedure |
| JP2011007887A (en) | 2009-06-23 | 2011-01-13 | Sharp Corp | Liquid-jetting developing device, and image forming apparatus equipped with liquid-jetting developing device |
| RU2563819C2 (en) | 2009-07-21 | 2015-09-20 | Керикс Байофармасьютикалз, Инк. | Drug forms of iron (iii) citrate |
| US20120121703A1 (en) | 2010-07-20 | 2012-05-17 | Japan Tobacco Inc. | Tablet containing ferric citrate |
| MY171864A (en) * | 2011-01-18 | 2019-11-05 | Japan Tobacco Inc | Iron(iii) citrate, substantially free of beta-iron hydroxide oxide |
-
2012
- 2012-01-18 MY MYPI2014002123A patent/MY171864A/en unknown
- 2012-01-18 JP JP2012007639A patent/JP2012162522A/en active Pending
- 2012-01-18 US US13/352,423 patent/US20120238622A1/en not_active Abandoned
- 2012-01-18 SG SG11201404168SA patent/SG11201404168SA/en unknown
- 2012-01-18 AU AU2012207967A patent/AU2012207967B2/en not_active Ceased
- 2012-01-18 CA CA2824646A patent/CA2824646C/en active Active
- 2012-01-18 EP EP12736578.1A patent/EP2666764A4/en not_active Withdrawn
- 2012-01-18 SG SG10201506517XA patent/SG10201506517XA/en unknown
- 2012-01-18 EP EP21192281.0A patent/EP3971162A1/en not_active Withdrawn
- 2012-01-18 WO PCT/JP2012/050885 patent/WO2012099139A1/en active Application Filing
-
2014
- 2014-02-19 US US14/184,062 patent/US9624155B2/en active Active
-
2016
- 2016-03-07 JP JP2016043504A patent/JP5944077B1/en active Active
- 2016-03-07 JP JP2016043505A patent/JP2016145232A/en active Pending
-
2017
- 2017-03-03 US US15/449,132 patent/US20180016220A1/en not_active Abandoned
- 2017-10-04 JP JP2017194089A patent/JP2018009027A/en active Pending
-
2019
- 2019-07-08 JP JP2019127189A patent/JP2019203006A/en active Pending
-
2020
- 2020-03-11 US US16/815,472 patent/US20210032186A1/en not_active Abandoned
-
2021
- 2021-03-19 JP JP2021045426A patent/JP2021098754A/en active Pending
-
2023
- 2023-01-10 JP JP2023001440A patent/JP7275410B2/en active Active
- 2023-05-02 JP JP2023075938A patent/JP2023095949A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP7275410B2 (en) | 2023-05-17 |
| JP2018009027A (en) | 2018-01-18 |
| NZ628678A (en) | 2016-02-26 |
| MY171864A (en) | 2019-11-05 |
| SG10201506517XA (en) | 2015-10-29 |
| JP2016175896A (en) | 2016-10-06 |
| US20210032186A1 (en) | 2021-02-04 |
| EP2666764A4 (en) | 2016-03-02 |
| JP2019203006A (en) | 2019-11-28 |
| JP2023095949A (en) | 2023-07-06 |
| AU2012207967B2 (en) | 2016-03-31 |
| JP2023038237A (en) | 2023-03-16 |
| US20120238622A1 (en) | 2012-09-20 |
| EP3971162A1 (en) | 2022-03-23 |
| JP5944077B1 (en) | 2016-07-05 |
| AU2012207967A1 (en) | 2015-11-12 |
| JP2012162522A (en) | 2012-08-30 |
| JP2021098754A (en) | 2021-07-01 |
| US20180016220A1 (en) | 2018-01-18 |
| CA2824646A1 (en) | 2012-07-26 |
| JP2016145232A (en) | 2016-08-12 |
| EP2666764A1 (en) | 2013-11-27 |
| US9624155B2 (en) | 2017-04-18 |
| CA2824646C (en) | 2020-07-14 |
| WO2012099139A1 (en) | 2012-07-26 |
| US20150025138A1 (en) | 2015-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201404168SA (en) | FERRIC CITRATE CONTAINING SUBSTANTIALLY NO β-OXIDIZED IRON HYDROXIDE | |
| HK1193551A1 (en) | Magnetic clasp | |
| EP2544749A4 (en) | Magnetically guided catheter | |
| EP2600929A4 (en) | Magnetically guided catheters | |
| GB201223473D0 (en) | Metal-containing compounds | |
| GB201314236D0 (en) | Metal-containing compounds | |
| PT2589307E (en) | Technical wetsuit | |
| PL2502875T3 (en) | Magnetic clutch | |
| EP2787386A4 (en) | Mask | |
| SG11201400895PA (en) | Electromagnetic energy-flux reactor | |
| EP2703677A4 (en) | Electromagnetic clutch | |
| GB201508581D0 (en) | Energy-saving magnetic lock | |
| PT2543408T (en) | Assisted-breathing mask | |
| EP2797567A4 (en) | Garment | |
| EP2669542A4 (en) | Electromagnetic clutch | |
| ZA201400208B (en) | Iron supplement composition | |
| EP2682221A4 (en) | Flux | |
| EP2690215A4 (en) | Iron | |
| PL2607273T3 (en) | Treatment assembly for ferromagnetic parts | |
| HK1210317A1 (en) | Agglomerating magnetic alkoxysilane-coated nanoparticles | |
| EP2682222A4 (en) | Flux | |
| HUE041483T2 (en) | Flux | |
| GB201104522D0 (en) | Complexes | |
| PL394335A1 (en) | Magnetic mixer | |
| GB201107199D0 (en) | Iron |